We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Study Investigates Potential Impact of Variant on COVID-19 Vaccine

News   Jan 20, 2021

 
Study Investigates Potential Impact of Variant on COVID-19 Vaccine
 
 
Advertisement
 

RELATED ARTICLES

How Bacteria in Cystic Fibrosis Patients Overcome Treatments

News

Researchers have discovered a slimy strategy used by bacteria to defeat antibiotics and other drugs used to combat infections afflicting people with cystic fibrosis.

READ MORE

Blood Tests Offer Early Indicator of Severe COVID-19

News

In a recent study, researchers report that a series of biomarkers, or biological signals, associated with white blood cell activation and obesity can predict severe outcomes in COVID-19 patients.

READ MORE

Janssen COVID-19 Vaccine Issued Emergency Use Authorization by the FDA

News

The U.S. Food and Drug Administration issued an Emergency Use Authorization (EUA) to the Janssen Pharmaceuticals Companies of Johnson & Johnson for its single-shot COVID-19 vaccine, called Ad.26.COV2S or JNJ-78436725.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE